| Sign In to gain access to subscriptions and/or personal tools. |
Oxygenator thrombosis: worst case after development of an abnormal pressure gradient - incidence and pathwayClinic for Thoracic, Cardiac and Vascular Surgery, Eberhard-Karls-University, Tuebingen, hp.wendel{at}uni-tuebingen.de
Clinic for Cardiothoracic Surgery, University of Regensburg, Tuebingen
Clinic for Thoracic, Cardiac and Vascular Surgery, Eberhard-Karls-University, Tuebingen
Clinic for Cardiothoracic Surgery, University of Regensburg, Tuebingen
Clinic for Thoracic, Cardiac and Vascular Surgery, Eberhard-Karls-University, Tuebingen The development of an abnormally high pressure gradient (APG) before the membrane oxygenator (MO) is a complication that occurs during some extracorporeal circulation (ECC) procedures. The present study deals with the incidence of an APG and discusses a probable causative pathway by comparing surface-coated and uncoated oxygenation systems. Five thousand six hundred and seventeen adult ECCs were carried out (2581 without and 3036 with surface coatings). The incidence of an APG, therefore, amounted to 0.03% in the group with coated systems and 4.3% in the uncoated group. In addition, an in vitro study demonstrated significantly reduced adhesion and activation of platelets and leucocytes when the surfaces of the MOs were coated with heparin or polypeptides. The advantages of coating surfaces of ECC devices possibly depend on the selective adsorption of particular plasma proteins. These will presumably form a biocompatible membrane on the surface, and minimize pathological deposit of fibrin, platelets and other blood cells, and, therefore, implicate the prevention of an oxygenator failure.
Perfusion, Vol. 16, No. 4,
271-278 (2001) This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
